Philippe Amouyal

CAVA

Philippe Amouyal serves as Director at CAVA Group, Inc. (CAVA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$533.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$533.3K

Companies Traded

CAVA, LXRX

Active Period

Nov 2023

2 total trades

Most Recent

Buy CAVA

Nov 17, 2023 · $331.8K

Philippe Amouyal's Insider Trading at CAVA Group, Inc. (CAVA)

Buys

1 · $331.8K

Sells

0 · $0.00

Total Shares Bought

10,000

Total Shares Sold

CAVA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 17, 2023	Buy	10,000	$33.18	$331.8K	0

Philippe Amouyal's Insider Trading at Lexicon Pharmaceuticals, Inc. (LXRX)

Buys

1 · $201.5K

Sells

0 · $0.00

Total Shares Bought

200,000

Total Shares Sold

LXRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 14, 2023	Buy	200,000	$1.01	$201.5K	240,332

Related Insiders

Kenneth Robert Bertram

officer: CLO & Secretary

CAVASell · Mar 6, 2026

Kelly Costanza

officer: Chief People Officer

CAVASell · Mar 2, 2026

Adam David Phillips

officer: Chief Accounting Officer

CAVASell · Mar 2, 2026

DEBBANE RAYMOND

Director

LXRXBuy · Feb 27, 2026

Invus Global Management, LLC

director, 10 percent owner:

LXRXBuy · Feb 4, 2026

Brett Schulman

CEO and President

CAVASell · Jan 27, 2026

Tricia K. Tolivar

Chief Financial Officer

CAVASell · Jan 27, 2026

Theodoros Xenohristos

Chief Concept Officer

CAVASell · Jan 27, 2026

Explore More Insider Trading Data

CAVA Insider Trading Activity

View all insider trades at CAVA Group, Inc.

Consumer Cyclical Sector Insider Trades

See insider activity across consumer cyclical stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity